Oligomerix, Inc., a privately held clinical stage company pioneering the development of oral, small molecule therapeutics ...
Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D experience collection. Among numerous updates to the main 10k Science VR application, including major ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...
Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties : As we prepare to end 2025, we would like to provide you with this open letter summarizing our ...
BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I ...
The RespireRx Group holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in ...
Money Moves is a recurring series where we chart the raises, grants, contracts, mergers and other funding news of tech companies across our regions. Have a tip? Email us at [email protected]. Life ...
WHITE RIVER JUNCTION, Vt., Nov. 18, 2025 /PRNewswire/ -- QUEL Imaging, a leader in biomedical optical characterization tools and services, and the Institut National d'Optique (INO), Canada's premier ...
FYR Bio ("FYR"), a leader in liquid-biopsy precision medicine for neuro-oncology, today announced a collaboration with NuvOx Therapeutics, Inc. ("NuvOx") supported by a two-year $1,976,897 ...
Burst Diagnostics Inc., an Innosphere graduate company, in a joint venture with FemmeLoop, will develop a low-cost, at-home hormone test and integrated digital health platform to provide women with ...
The grant will fund a three-year multicenter study performed in collaboration with major medical centers and key opinion leaders around the U.S. CND Life Sciences receives $3M NIH grant to study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results